Meningiomas are grouped by maximum diameter into small (generally under 3 cm), large (roughly 3 to 5 cm), and giant (over 5 cm), though exact cutoffs vary somewhat between institutions and studies. These categories are not arbitrary labels. They guide decisions about whether to watch a tumor with periodic imaging, operate on it, or treat it with focused radiation, and they predict complication risk and recovery. The relationship between size, symptoms, and outcomes is more layered than a simple diameter number might suggest.
Where the Size Thresholds Come From
There is no single international standard that locks in meningioma size categories. In practice, most neurosurgical literature treats tumors under about 3 cm in maximum diameter as small, those between 3 and 5 cm as large, and anything over 5 cm as giant. The 5 cm cutoff for “giant” is the most consistent across studies and is used in multicenter research as the defining threshold for giant intracranial meningiomas.1PubMed Central. The Surgical Risk Factors of Giant Intracranial Meningiomas: A Multi-Centric Retrospective Analysis of Large Case Series Some research groups draw the line between “small” and “large” at 4 cm rather than 3, especially when studying cognitive outcomes.2Journal of Neurosurgery. Effects of intracranial meningioma location, size, and surgery on neurocognitive functions: a 3-year prospective study The lower boundary is even less standardized. A meta-analysis examining the natural history of small meningiomas focused on tumors under 2.5 to 3 cm, reflecting the range where watchful waiting is most commonly offered.3Journal of Neurosurgery. Treatment decision making based on the published natural history and growth rate of small meningiomas: A review and meta-analysis
The upshot is that “small,” “large,” and “giant” are practical clinical buckets, not precise biological categories. Two surgeons looking at the same 4.5 cm meningioma might label it differently. What matters more than the label is how that size, combined with location and growth behavior, shapes management.
Diameter Versus Volume
Most size classifications rely on maximum diameter measured on MRI, but a growing body of evidence argues that tumor volume gives a more accurate picture. A spherical 3 cm meningioma and a flat, pancake-shaped 3 cm meningioma occupy very different amounts of space inside the skull. Diameter lumps them together; volume does not.
Several approaches exist for estimating volume from standard imaging. Simple formulas that multiply the three measured dimensions by a constant work surprisingly well. Two of these, known by their shorthand as 1/2 × ABC and 2/3 × SH, matched slice-by-slice volumetric measurements closely, with near-perfect correlation.4PubMed Central. Simple Ways to Estimate Meningioma Volume: Can ABC- and SH-Derived Methods Be Used in Clinical Practice Reliably? Still, these formula-based methods tend to overestimate actual volume. A study comparing linear formulas, manual slice-tracing, and computer-based methods found the linear approach overestimated volume in about two-thirds of cases, with errors averaging around 12%.5PubMed. Volumetric measurement of intracranial meningiomas: a comparison between linear, planimetric, and machine learning with multiparametric voxel-based morphometry methods That overestimation can matter when clinicians are deciding between surgery and surveillance based on whether a tumor seems to be growing.
Automated tools driven by deep learning are now being tested to standardize these measurements. One fully automated system reliably detected and segmented meningiomas on routine MRI, offering the kind of consistent, reproducible volume readings that make growth tracking more sensitive.6PubMed Central. Fully automated detection and segmentation of meningiomas using deep learning on routine multiparametric MRI These methods are not yet widespread in clinical settings, but they point toward a future where volume replaces diameter as the primary yardstick.
How Small Meningiomas Grow Over Time
A small, incidentally discovered meningioma does not necessarily mean surgery is around the corner. Many of these tumors grow slowly or not at all. In one cohort followed over time, about 27% of untreated meningiomas showed no radiological growth, and another 14% actually shrank.7PubMed Central. Growth dynamics of untreated meningiomas A separate study of conservatively managed patients found an average tumor doubling time of over 21 years, with the slowest-growing tumors taking well over a century to double in volume if their pace held.8Neurosurgery. The natural history of incidental meningiomas
That said, “average” hides a lot of variation. Growth rates range from essentially zero to rapid expansion. On a group level, meningioma growth follows a decelerating curve: tumors grow faster when they are smaller and slow down as they enlarge.7PubMed Central. Growth dynamics of untreated meningiomas Tumor size at the time of diagnosis and whether the patient had multiple meningiomas were linked to whether growth occurred, whereas age and sex were not.
When Small Becomes a Problem
Size alone does not determine whether a small meningioma causes trouble. Location and growth speed matter enormously. A meta-analysis found that patients whose tumors started under 2 cm rarely developed new or worsening symptoms over a median follow-up of about 4.5 years. But for tumors between 2 and 2.5 cm, the growth rate was the differentiator. Among those growing faster than 10% per year, 42% of patients developed symptom progression, compared with zero percent in the slow-growth group.3Journal of Neurosurgery. Treatment decision making based on the published natural history and growth rate of small meningiomas: A review and meta-analysis For tumors between 2.5 and 3 cm, about 17% of patients developed new symptoms regardless of growth rate.
This is what makes the surveillance approach for small meningiomas reasonable but not risk-free. Periodic MRI scans track diameter or volume over time, and a consistently stable tumor can often be left alone indefinitely. The trigger for intervention is usually documented growth, new symptoms, or both. The psychological cost of this waiting game, however, is real. A prospective study found that patients under a watch-and-wait strategy carried a significant psychological burden simply from knowing a brain tumor existed, often without being offered any supportive measures like access to psycho-oncological care.9PubMed Central. Psychological Burden in Meningioma Patients under a Wait-and-Watch Strategy and after Complete Resection Is High—Results of a Prospective Single Center Study
What Makes Giant Meningiomas Different Surgically
Removing a giant meningioma is a fundamentally different operation than removing a small one. Giant tumors tend to envelop or compress critical blood vessels and nerves, making dissection far more hazardous. They have a more prominent blood supply, and the brain tissue around them is often swollen. A study evaluating outcomes after giant meningioma surgery reported a mortality rate of 4%, with interdisciplinary cooperation described as essential for managing complications like blood clots in the lungs and postoperative bleeding in the surgical cavity.10Egyptian Journal of Neurosurgery. Evaluation of surgical outcome of giant intracranial meningiomas
In elderly patients, the stakes are higher still. One study found that major complications were roughly twice as common among giant meningioma patients compared to those with smaller tumors, with postoperative bleeding severe enough to require a second surgery accounting for about 18% of the giant meningioma group.11PubMed Central. Surgery on giant meningiomas in very old patients entails frequent postoperative intracranial hemorrhages and atypical histopathology Giant tumor size showed a roughly threefold increase in the odds of developing major complications. These findings do not mean surgery is off the table for giant meningiomas in older patients, but they underscore that the decision involves careful weighing of risks against expected benefit.
Location Adds Another Layer
A 4 cm meningioma over the top of the brain is a very different clinical problem than a 4 cm meningioma pressed against the optic nerves at the skull base. Location influences surgical access, complication profiles, and functional outcomes in ways that modify what “large” means in practice.
Research on anterior midline skull base meningiomas illustrates this. Patients with the largest tumors in that location had significantly worse functional scores at hospital discharge compared to patients with smaller tumors. Complication rates were roughly two and a half times higher in the larger tumor groups compared to the smallest group. And when large skull base tumors were accompanied by substantial brain swelling, functional scores dropped even further.12Brain and Spine. Impact of tumor size and peritumoral edema on outcomes and complications in anterior midline skull base meningiomas Location and size together are a stronger predictor of outcomes than either alone.
Peritumoral Edema and Why Swelling Can Be Worse Than Size
The brain swelling surrounding a meningioma, called peritumoral edema, can cause as many symptoms as the tumor itself. A small meningioma with dramatic surrounding edema can produce severe headaches, seizures, and neurological deficits, while a large meningioma with minimal swelling may remain asymptomatic for years. The presence and degree of edema are not simply a function of how big the tumor is.
The molecular driver of this swelling appears to be VEGF, a protein that promotes blood vessel growth and increases vascular leakiness. Meningiomas with severe surrounding edema express substantially higher levels of VEGF than those with minimal edema, and the VEGF protein shows a decreasing gradient with increasing distance from the tumor into surrounding brain tissue.13Annals of Clinical & Laboratory Science. Expression of Vascular Endothelial Growth Factor in Human Meningiomas and Peritumoral Brain Areas Additional matrix-remodeling enzymes are also elevated in meningiomas with severe surrounding brain swelling, suggesting multiple molecular pathways contribute to edema formation.14PubMed. Correlation of clinical and biological parameters with peritumoral edema in meningioma The key clinical point is that VEGF expression correlates with edema severity but not with whether the tumor is histologically more aggressive. A low-grade, benign-looking meningioma can still cause heavy swelling if it produces enough VEGF.
How Completeness of Removal Relates to Recurrence
For meningiomas that do undergo surgery, the extent of removal is a strong predictor of whether the tumor comes back. The traditional grading system for surgical completeness, known as the Simpson scale, ranges from a Grade I removal (tumor plus its dural attachment plus any invaded bone) down to a Grade IV removal (partial removal leaving tumor behind). The relationship between that scale and recurrence is consistent across studies. In one large analysis, recurrence rates were 5% after Grade I resection, 22% after Grade II, 31% after Grade III, and 35% after Grade IV.15PubMed. Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma Another study confirmed that Simpson grade and whether the tumor was completely or only partially removed were both significant predictors of how long patients remained recurrence-free.16PubMed. WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant?
Giant meningiomas are inherently harder to remove completely because they encase more structures. This feeds directly into their higher recurrence rates after surgery. But size is not the only obstacle. Skull base location makes complete removal difficult regardless of tumor dimensions, because critical arteries and cranial nerves pass through the same tight spaces.
Radiosurgery for Small and Medium Tumors
Stereotactic radiosurgery, which delivers tightly focused radiation in one or a few sessions, has become a standard option for small to medium meningiomas, particularly those in locations where surgery carries high risk. For these tumors, radiosurgery can match the best surgical outcomes. One comparison found that radiosurgery achieved a seven-year progression-free survival rate of 95%, statistically indistinguishable from the 96% seen after the most complete type of surgical resection.17PubMed. Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small- to medium-size meningiomas Radiosurgery actually outperformed less-complete surgical removals.
For tumors near the optic nerves, where a single high dose of radiation could damage vision, treatment is often split into several smaller doses. A series of 100 patients with meningiomas near the optic apparatus treated with five-fraction radiosurgery achieved tumor control in 98% of cases over a mean follow-up of about three and a half years, and tumor volume did not predict whether the tumor shrank or stayed stable.18PubMed Central. Hypofractionated Gamma Knife Icon Radiosurgery for Perioptic Meningiomas: Clinical and Radiological Outcomes in a Series of 100 Patients For larger tumors that exceed the volume safely treatable in one session, staged radiosurgery across two treatment courses has shown similarly high control rates above 97%.19PubMed Central. Dose-staged Gamma Knife radiosurgery for meningiomas: A retrospective study in a single center
The practical implication is that size determines which radiation approach is feasible. Small tumors near critical structures are strong candidates for radiosurgery as a primary treatment. Larger tumors may require staged radiation, or radiation may serve as a supplement after surgery that could not remove every last bit of tumor.
Preoperative Embolization for Large and Giant Tumors
Before operating on a large or giant meningioma, surgeons sometimes request preoperative embolization, a procedure that threads a catheter into the tumor’s feeding arteries and blocks them with tiny particles to reduce blood flow. In theory, this should make the subsequent surgery less bloody and easier to manage. In practice, the evidence is mixed.
One large analysis found that embolization did not independently predict blood loss, extent of resection, or complications. The factors that actually drove blood loss were how thoroughly the tumor’s vessels were blocked during the embolization, skull base location, and male sex.20PubMed Central. Preoperative embolization of intracranial meningiomas: efficacy, technical considerations, and complications A separate study found no difference in blood loss between embolized and non-embolized patients, though embolization was associated with a modest reduction in surgical time by roughly 20 minutes.21PubMed. Preoperative embolization of meningiomas with polyvinyl alcohol particles: The benefits are not outweighed by risks Size and location of the meningioma did not change these results in subgroup analyses.
Embolization remains common in practice for giant meningiomas, where expected blood loss is high and any reduction could matter. But the procedure itself carries a small risk of stroke and is not guaranteed to make surgery safer. It is a judgment call, not a reflex.
Cognitive Effects of Tumor Size
Meningiomas can affect thinking and memory even before they cause classic neurological symptoms like weakness or vision loss. A three-year prospective study found that patients with tumors larger than 4 cm had more severe neurocognitive deficits than those with smaller tumors.2Journal of Neurosurgery. Effects of intracranial meningioma location, size, and surgery on neurocognitive functions: a 3-year prospective study A systematic review confirmed that tumor size, along with age, edema, and skull base location, was associated with worse performance across multiple cognitive domains.22Brain and Spine. Neurocognitive evaluation in patients with intracranial Meningiomas: A systematic review
Interestingly, one prospective study that tracked patients before and after surgery found that tumor volume had no effect on how much cognitive function improved after removal.23PubMed Central. Surgical treatment of meningiomas improves neurocognitive functioning and quality of life – a prospective single-center study In other words, while bigger tumors cause more cognitive trouble up front, patients with large tumors can recover just as well as those with small tumors after successful surgery. The brain’s ability to bounce back does not appear to be permanently compromised by the tumor’s size, at least for the patients studied.
Tumor Biology Does Not Always Track With Size
It would be convenient if size mapped neatly onto aggressiveness, but it does not. The World Health Organization classifies meningiomas into three grades based on their microscopic features: Grade 1 (benign, making up the vast majority), Grade 2 (atypical, with some worrying features), and Grade 3 (anaplastic, frankly malignant). A tiny Grade 3 meningioma is far more dangerous than a giant Grade 1 tumor. The Ki-67 proliferation index, a marker of how quickly tumor cells are dividing, rises sharply across grades, with average values roughly tripling from Grade 1 to Grade 2 and doubling again from Grade 2 to Grade 3.24Journal of Medical Sciences and Health. A Histomorphological Study of Meningiomas According to Latest CNS 5 th Edition WHO Classification 2021 and Co-relation of Grading with Ki-67 Proliferation Index
Genetic patterns add another layer. The most common mutation in meningiomas involves loss of a gene called NF2, which occurs in both low- and high-grade tumors. Meningiomas without NF2 mutations tend to carry a different set of genetic changes and are more frequently benign.25PubMed Central. Meningioma: current updates on genetics, classification, and mouse modeling None of these molecular features are determined by tumor diameter. A small, genetically aggressive meningioma can outpace a large, genetically quiet one. This is why pathology after surgery and, increasingly, molecular profiling are central to determining follow-up intensity and whether additional treatment is needed.
Cost and Resource Implications of Tumor Size
Larger meningiomas cost more to treat. That is unsurprising, but the data put numbers on the intuition. A cost analysis of open surgery versus radiosurgery for meningiomas found that maximum tumor size was an independent driver of total surgical costs on multivariate analysis, alongside hospital length of stay.26World Neurosurgery. Assessment of Costs in Open Microsurgery and Stereotactic Radiosurgery for Intracranial Meningiomas Bigger tumors mean longer operations, more ICU time, higher complication rates, and more frequent need for repeat intervention. The cost difference is one reason the option of radiosurgery for small and medium meningiomas is attractive from a health-system perspective as well as a clinical one.
Hormonal Influences on Growth
Meningiomas are about twice as common in women as in men, and part of the explanation involves hormones. Many meningiomas express receptors for progesterone, and some express estrogen receptors. During pregnancy, when hormone levels surge, previously stable meningiomas can accelerate in growth and cause new symptoms.27PubMed Central. Diagnosis, Treatment, and Management Strategy of Meningioma during Pregnancy This has practical relevance for size classification and surveillance timing. A small, stable meningioma in a woman planning pregnancy may warrant closer follow-up imaging during and after pregnancy, because the tumor could jump categories during that window. The hormonal connection also explains occasional case reports of rapid growth in patients taking exogenous hormones, though the evidence on that link remains less settled than the pregnancy data.
Meningiomas in Children
Meningiomas in children are rare, accounting for a small fraction of pediatric brain tumors. When they do occur, they sometimes present in unusual locations and at sizes that would be classified as giant. One case report described a giant intraparenchymal meningioma in a child, a presentation so uncommon that a review of the literature found only 21 similar cases in children.28PubMed Central. Giant Intraparenchymal Meningioma in a Female Child: Case Report and Literature Review Pediatric meningiomas are more likely to be higher-grade and more likely to recur than their adult counterparts, which means the same size classification carries different clinical weight in a child than in a middle-aged adult. Treatment tends to be more aggressive because of the longer time horizon over which a recurrence could develop.